Article

Immunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.

California National Primate Research Center, University of California Davis, Davis, CA 95616, United States.
Vaccine (Impact Factor: 3.77). 12/2009; 28(6):1481-92. DOI: 10.1016/j.vaccine.2009.11.061
Source: PubMed

ABSTRACT In a previously developed infant macaque model mimicking HIV infection by breast-feeding, we demonstrated that intramuscular immunization with recombinant poxvirus vaccines expressing simian immunodeficiency virus (SIV) structural proteins provided partial protection against infection following oral inoculation with virulent SIV. In an attempt to further increase systemic but also local antiviral immune responses at the site of viral entry, we tested the immunogenicity of different orally administered, replicating vaccines. One group of newborn macaques received an oral prime immunization with a recombinant vesicular stomatitis virus expressing SIVmac239 gag, pol and env (VSV-SIVgpe), followed 2 weeks later by an intramuscular boost immunization with MVA-SIV. Another group received two immunizations with live-attenuated SIVmac1A11, administered each time both orally and intravenously. Control animals received mock immunizations or non-SIV VSV and MVA control vectors. Analysis of SIV-specific immune responses in blood and lymphoid tissues at 4 weeks of age demonstrated that both vaccine regimens induced systemic antibody responses and both systemic and local cell-mediated immune responses. The safety and immunogenicity of the VSV-SIVgpe+MVA-SIV immunization regimen described in this report provide the scientific incentive to explore the efficacy of this vaccine regimen against virulent SIV exposure in the infant macaque model.

0 Bookmarks
 · 
59 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Systematic K–Ar dating and geochemical analyses of Paleogene cauldrons in the Sanin Belt of SW Japan have been made to explore the relationship between the timing of their formation and the Paleogene subduction history of SW Japan documented in the Shimanto accretionary complex. We also examine the magma sources and tectonics beneath the backarc region of SW Japan at the eastern plate boundary of Eurasia.Fifty-eight new K–Ar ages and 19 previously reported radiometric age data show that the cauldrons formed during Middle Eocene to Early Oligocene time (43–30 Ma), following a period of magmatic hiatus from 52 to 43 Ma. The hiatus coincides with absence of an accretionary prism in the Shimanto Belt. Resumption of the magmatism that formed the cauldron cluster in the backarc was concurrent with voluminous influx of terrigenous detritus to the trench, as a common tectono-thermal event within a subduction system.The cauldrons are composed of medium-K calc-alkaline basalts to rhyolites and their plutonic equivalents. These rocks are characterized by lower concentrations of large ion lithophile elements (LILE) including K2O, Ba, Rb, Th, U and Li, lower (La/Yb)n ratios, lower initial Sr isotopic ratios (0.7037–0.7052) and higher εNd(T) values (−0.5 to +3.5) relative to Late Cretaceous to Early Paleogene equivalents. There are clear trends from enriched to depleted signatures with decreasing age, from the Late Cretaceous to the Paleogene. The same isotopic shift is also confirmed in lower crust-derived xenoliths, and is interpreted as mobilization of pre-existing enriched lithospheric mantle by upwelling depleted asthenosphere.Relatively elevated geothermal gradients are presumed to have prevailed over wide areas of the backarc and forearc of the SW Japan arc-trench system during the Eocene to Oligocene. Newly identified Late Eocene low silica adakites and high-Mg andesites in the Sanin Belt and Early Eocene A-type granites in the SW Korea Peninsula probably formed due to upwelling of hot asthenosphere and subduction of a young plate.The backarc region was an extensional tectonic setting, and some Paleogene rift basins and Sanin Belt cauldrons occur in linear arrays. The Eocene–Oligocene Sanin-SE Korea continental arc lies on the NE extension of the East China Sea Basin, the initial stage of which probably formed by continental arc rifting. This rifting may have been triggered by upwelling of hot asthenosphere into the wedge space created by rollback of the subducted slab, in response to decreased convergence rate between the Pacific and Eurasian plates.Research highlights► The Sanin cauldrons formed during Middle Eocene to Early Oligocene time (43–30 Ma). ► Geochemical data show trends of depletion from the Late Cretaceous to the Paleogene. ► Isotopic shift is explained as mobilization of lithospheric mantle by asthenosphere. ► Rifting may have been triggered by upwelling of hot asthenosphere. ► Upwelling of asthenosphere was caused by rollback of subducted Pacific slab.
    Journal of Asian Earth Sciences 01/2011; 40(2):509-533. · 2.38 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Development of an effective HIV/AIDS vaccine remains a big challenge, largely due to the enormous HIV diversity which propels immune escape. Thus novel vaccine strategies are targeting multiple variants of conserved antibody and T cell epitopic regions which would incur a huge fitness cost to the virus in the event of mutational escape. Besides immunogen design, the delivery modality is critical for vaccine potency and efficacy, and should be carefully selected in order to not only maximize transgene expression, but to also enhance the immuno-stimulatory potential to activate innate and adaptive immune systems. To date, five HIV vaccine candidates have been evaluated for efficacy and protection from acquisition was only achieved in a small proportion of vaccinees in the RV144 study which used a canarypox vector for delivery. Conversely, in the STEP study (HVTN 502) where human adenovirus serotype 5 (Ad5) was used, strong immune responses were induced but vaccination was more associated with increased risk of HIV acquisition than protection in vaccinees with pre-existing Ad5 immunity. The possibility that pre-existing immunity to a highly promising delivery vector may alter the natural course of HIV to increase acquisition risk is quite worrisome and a huge setback for HIV vaccine development. Thus, HIV vaccine development efforts are now geared toward delivery platforms which attain superior immunogenicity while concurrently limiting potential catastrophic effects likely to arise from pre-existing immunity or vector-related immuno-modulation. However, it still remains unclear whether it is poor immunogenicity of HIV antigens or substandard immunological potency of the safer delivery vectors that has limited the success of HIV vaccines. This article discusses some of the promising delivery vectors to be harnessed for improved HIV vaccine efficacy.
    Frontiers in microbiology. 01/2014; 5:439.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Oncolytic viruses (OVs) are highly immunogenic and this limits their use in immune-competent hosts. Although immunosuppression may improve viral oncolysis, this gain is likely achieved at the cost of antitumoral immunity. We have developed a strategy wherein the immune response against the OV leads to enhanced therapeutic outcomes. We demonstrate that immunization with an adenoviral (Ad) vaccine before treatment with an oncolytic vesicular stomatitis virus (VSV) expressing the same tumor antigen (Ag) leads to significantly enhanced antitumoral immunity. Intratumoral replication of VSV was minimally attenuated in Ad-immunized hosts but extending the interval between treatments reduced the attenuating effect and further increased antitumoral immunity. More importantly, our combination approach shifted the immune response from viral Ags to tumor Ags and further reduced OV replication in normal tissues, leading to enhancements in both efficacy and safety. These studies also highlight the benefits of using a replicating, OV to boost a pre-existing antitumoral immune response as this approach generated larger responses versus tumor Ag in tumor-bearing hosts than could be achieved in tumor-free hosts. This strategy should be applicable to other vector combinations, tumor Ags, and tumor targets.
    Molecular Therapy 08/2010; 18(8):1430-9. · 7.04 Impact Factor

Full-text (2 Sources)

View
11 Downloads
Available from
Jun 5, 2014